COVID-19 Prevention and Treatment
Here you’ll find the most comprehensive and current information when it comes to the prevention and treatment of COVID-19.
COVID-19 prevention and treatments are constantly improving. Check here for the latest advances in prevention and disease management. Read about breaking research and news concerning vaccines, monoclonal antibodies, and other therapeutics with a focus on the immune compromised.
ADDITIONAL READING
Now there is a new trial (SUPERNOVA) of an updated mix of monoclonal antibodies that hopes to provide durable protection against present and future variants of concerns.
Now there is a new trial (SUPERNOVA) of an updated mix of monoclonal antibodies that hopes to provide durable protection against present and future variants of concerns.
We encourage all those with CLL / SLL to print and politely share CLL Society’s Official Statement with your healthcare team
As the risk of COVID-19 exposure stretches on, we have updated our official statement concerning working conditions for people with CLL / SLL (Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma) that you can download for your own reference and to share with the appropriate people in your life including HR and co-workers.
In this interview, Dr. Brian Koffman spoke with Dr. Shmuel Shoham, a Professor of Clinical Medicine at Johns Hopkins University. Dr. Shoham specializes in the infectious disease care of immunocompromised patients, including those with leukemias and lymphomas. They discussed the use of convalescent plasma to treat COVID-19.
In the new COVID-19 guidelines released on August 11th, the US Centers for Disease Control and Prevention (CDC) made a change in their recommended infection control measures that are geared more towards increasing the focus on individuals understanding their own risk level for developing severe COVID-19 disease, making a personal decision
RECENT NEWS
When appropriate, the CLL Society will be posting updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.
